The biopharmaceutical landscape is evolving fast, with innovation in proteins, lipids, and RNA therapeutics. As these molecules move through the development pipeline, one challenge looms large: ensuring their stability. Selecting the right stability measurement platform is therefore a mission-critical decision.
That’s why we’ve created A Buyer’s Guide to Stability Measurement Platforms for Biopharmaceuticals. This comprehensive resource outlines what you to know about the latest technologies, key considerations, and best practices to simplify your decision-making process.
Stability analysis is the foundation of success in biopharmaceuticals. Whether it’s monoclonal antibodies (mAbs), RNA-based therapeutics, or lipid nanoparticles, understanding how these molecules behave under varying conditions is essential for:
But not all stability measurement tools are equal. The guide explores why Differential Scanning Calorimetry (DSC) stands out as the gold standard for comprehensive, reliable, and reproducible data.
Here’s a sneak peek at what you’ll discover:
This guide is tailored for pharmaceutical scientists, R&D professionals, and decision-makers who want to:
Making the wrong choice in stability measurement can cost your team time, money, and credibility. With our Buyer’s Guide, you’ll gain the clarity and confidence to invest in a platform that aligns with your goals and delivers measurable results.
Please login or register for free to download A Buyer’s Guide to Stability Measurement Platforms for Biopharmaceuticals today and discover how tools like the MicroCal PEAQ-DSC can revolutionize your approach to stability analysis.
In the dynamic landscape of biopharmaceuticals, proteins, protein derivatives, lipids, and nucleic acids stand at the forefront of innovation. Among these, monoclonal antibodies (mAbs) represent the largest class currently on the market or in development, while nucleic acids represent novel modalities of drugs and vaccines with a growing presence in academic research and in development pipelines.
Despite the diversity of biopharmaceuticals, a fundamental challenge persists: these products are based on complex molecules and molecular assemblies that are often unstable in solution and can undergo degradation over time. As a result, there is a clear need for analytical methods that can help identify candidates with favorable stability profiles and support effective manufacturing and storage over long periods throughout development and commercialization.
Real-time stability assays, required to assess the shelf life of biomolecules in solution, are time-consuming. For this reason, faster predictive methods have been established to accelerate the process of developing stable biologic drug formulations and process conditions. The most common of these predictive approaches are thermal unfolding methods, which determine the temperature at which a protein or other biomolecule undergoes thermal transitions, providing valuable data for comparative studies.
By generating unfolding or thermal stability profiles, researchers can compare the intrinsic stability of biomolecules under a given set of conditions during protein engineering and candidate selection. Further, thermal stability profiles can be generated for any candidate molecule in a range of buffers and co-solutes to help identify stabilizing/destabilizing conditions during pre-formulation and formulation development.
In process development, thermal stability assays are used to identify purification strategies that will maximize yields by determining stable loading and elution buffers for chromatographic processes. In the following stages of scaling-up and manufacturing, thermal stability assays are key for understanding changes in the high-order structure of the candidate and as predictors of long-term stability tests. Finally, the thermal stability profile is one of the golden standards in quality control, batch-to-batch comparisons, and drug approvals.
In practice, a molecule that undergoes a thermal transition at relatively low temperature is often more susceptible to degradation pathways associated with partially unfolded states, while a molecule requiring higher temperatures for transition is often considered more stable. At the same time, the most appropriate stability readout depends on the question being asked, the sample type, and the information needed from the assay platform.
Several technologies are available for measuring the stability of proteins and other biomolecules. Among these, differential scanning calorimetry (DSC) is often regarded as a reference method because it directly measures the heat absorbed or released during thermal unfolding. This makes it especially valuable for obtaining detailed thermodynamic information and for characterizing complex unfolding behavior.
Differential scanning fluorimetry (DSF) is a widely used and highly practical approach for screening purposes. It typically requires less sample, supports higher throughput, and can be very effective for comparing relative stability trends across many conditions. Because it relies on changes in fluorescence during unfolding, it is often best suited to rapid ranking, early screening, and decision-making in workflows where sample conservation and speed are important.
Each technique therefore has clear strengths. DSC offers direct thermodynamic information, high reproducibility, and broad applicability across biomolecule classes. DSF offers simplicity, speed, and efficiency for screening a large number of conditions. At the same time, both methods have limitations: DSC is lower throughput and typically requires large sample amounts, while DSF may be more sensitive to optical artifacts, dye effects (if no tryptophan is present), or interpretation challenges depending on the sample and assay design. The two techniques are complementary, answering different stability questions at different stages of the workflow.
| A
S K Y O U R S E L F | Do I need a versatile tool for present and future project needs? |
|---|---|
| Is it necessary to characterize the stability of individual domains in a multi-domain protein? | |
| Do I need to detect subtle changes in the stability of my protein? | |
| Is reproducibility a priority? | |
| Is high-throughput a priority? | |
| Which temperature range do I need? | |
| Is some tryphtophan present in my sample or do I rely on external dyes? | |
| What is the added cost of running the technology? | |
| What level of service and support do I need for my instrument? |
Selecting the optimal biomolecular stability measurement platform requires a clear grasp of the fundamental differences between available technologies. Vendors often employ their own specialized terminology and present instruments in ways that highlight particular features. However, the starting point for any decision should be a thorough understanding of your specific application requirements and how different product specifications and features align with them.
A practical comparison between DSC and DSF should focus on the type of information each method provides and the stage of development in which it is most useful.
DSC is particularly valuable when direct thermodynamic characterization, high reproducibility, and detailed unfolding profiles are required. It is well suited to proteins, lipids3, nucleic acids, and complex biomolecular assemblies with many transitions. DSC can be especially informative for studies where unfolding complexity or domain-level behavior matters. Because of its exceptional reproducibility, DSC is widely used for biosimilarity and comparability studies. This is why it was a key technology in the approval of the biotherapeutic drug, Remsima, a biosimilar to Remicade. Researchers at Amgen found DSC the best technique for detecting subtle changes in the higher order structure of a multi-domain protein, correlated with the oxidation of the biotherapeutic product1, 6.
DSF is often preferred when the goal is rapid screening of a large number of conditions with minimal sample consumption. It can be a strong choice for early-stage formulation work, buffer screening, and ranking candidate molecules, particularly when the main need is to identify relative rather than absolute stability differences.
In many development programs, the most effective strategy is not to choose one method over the other, but to use them together in a complementary workflow. DSF can be used to triage and prioritize conditions and offers a fast and efficient way to screen large sample sets, while DSC can then provide direct, high-resolution thermodynamic insight with a deeper, more quantitative view of stability for selected candidates.
Selecting the right tool for each decision point, or using both in a complementary workflow, helps ensure that stability data are both scientifically robust and operationally useful for each workflow step, so it can improve candidate selection, formulation design, and comparability assessment the most.
In the following example, the thermal stability of a monoclonal antibody (mAb) sample is evaluated using three complementary readouts: DSC, intrinsic DSF, and extrinsic DSF (Figure 1, DSC (red), intrinsic DSF (blue), extrinsic DSF (yellow). The DSF data is shown as 1st derivative readout.
![[Figure 1 WP160725stabilitybuyers - A Buyer's Guide to Stability Measurement Platforms for Biopharmaceuticals.png] Figure 1 WP160725stabilitybuyers.jpg](https://dam.malvernpanalytical.com/64a0e17a-164a-4749-b195-b2d800eddd60/Figure%201%20WP160725stabilitybuyers_Original%20file.jpg)
Figure 1. (Left) Thermal stability of a mAb sample measured with three techniques as overlay: DSC (red), intrinsic DSF (blue), extrinsic DSF (yellow), neat (middle) and after oxidative stress (right).
Each technique reports on thermal unfolding through a different measurement principle and therefore provides a distinct view of the stability profile. DSC directly measures the heat changes associated with unfolding and follows the incremental progression of thermal transitions; as a result, the amplitude and area of DSC peaks are directly related to the amount of material undergoing a transition. DSF, by contrast, monitors changes in fluorescence as the protein unfolds, generating a cumulative signal that reflects the fluorescence properties of the intrinsic or extrinsic fluorophores and the relative fluorescence contribution of folded and unfolded species at each temperature.
When DSC unfolding profiles of the mAb sample neat (Fig. 1, middle) and after oxidative stress (Fig 1, right) are overlaid with the corresponding first-derivative traces of intrinsic and extrinsic DSF data, the techniques provide complementary perspectives on the unfolding behavior. DSF can sensitively highlight thermal stability shifts and support efficient comparison between sample conditions, while DSC can provide the additional thermodynamic resolution needed to assign specific unfolding events, such as Fab transitions, with greater confidence. As the transition of the Fab binding domain is typically larger than that of the CH2 and CH3 domains, DSC makes it easier to identify each domain and see differences in high-order-structure (HOS).
A useful consideration is whether the chosen method should address current needs while remaining adaptable to future project requirements across different biomolecule classes. DSC is a versatile and direct thermal stability technique that can be applied to proteins4, lipids2, nucleic acids3, and their assemblies [2, 5, 7]. Because it measures thermal unfolding directly through heat changes, it does not require additional reagents and is independent of the number and location of intrinsic fluorophores, making it applicable to a broad range of sample types without method-specific adaptation (Fig.2).
![[Figure 4 WP160725stabilitybuyers - A Buyer's Guide to Stability Measurement Platforms for Biopharmaceuticals.jpg] Figure 4 v3 WP160725stabilitybuyers.png](https://dam.malvernpanalytical.com/0f7feb06-6794-4aac-bbe4-b2ea008bcd71/Figure%204%20v3%20WP160725stabilitybuyers_Original%20file.png)
Figure 2: Overlays of blank-corrected and baseline-subtracted DSC traces of RNA, mAb, mRNA LNP, and DPPC samples showing its versatility.
Intrinsic fluorescence-based methods assess protein stability by monitoring changes in the local environment of tryptophan residues as the protein unfolds. Intrinsic fluorescence methods are not directly applicable to nucleic acids, lipids, and their assemblies, as these sample types lack the relevant fluorophores. Here, extrinsic fluorescent dyes can be used for these molecules, though their use requires careful method development, as the dye may influence the measurement depending on the sample and assay conditions.
However, when throughput is a priority and the goal is early triage or screening across many conditions, DSF offers practical advantages in speed and sample efficiency. For detailed thermodynamic characterization, or for samples where the assumptions underlying fluorescence-based measurements may not fully apply, DSC provides direct, label-free data that can support a more complete interpretation.
DSC’s high reproducibility and its ability to monitor structural changes of the entire protein make it ideal for measuring and comparing the stability and cooperativity of transitions of individual subdomains. Menzen and Friess reported “...high reproducibility of DSC...justifies the validity of single measurement for the sake of time and material”4. DSF can provide useful information about subdomain transitions in many cases.
In the data for two different mAb, measured with DSC and intrinsic DSF (Fig. 3, DSC (red), intrinsic fluorescence (blue)), the data for mAB1 is in very good agreement with each other for both transitions. mAb3 shows differences in the early transition by approx. 3 °C, while following the same overall trend and shows a really good agreement for the main transition. The reason for the small temperature difference can be found in the assumption that in mAb3 the tryptophan residues are not distributed throughout the protein in an ideal way for fluorescence detection; some domains will have buried tryptophan residues, and some will not. This might lead to a lower resolved early transition and thus a slightly shift in transition position.
![[Figure 2 v2 WP160725stabilitybuyers - A Buyer's Guide to Stability Measurement Platforms for Biopharmaceuticals.png] Figure 2 WP160725stabilitybuyers .jpg](https://dam.malvernpanalytical.com/d5b85314-324a-4789-9454-b2d800eead88/Figure%202%20WP160725stabilitybuyers%20_Original%20file.jpg)
Figure 3: DSC thermograms (red) and 1st derivative of intrinsic DSF data (blue) for two mAb candidates from a stress stability study.
DSC, as a first-principle calorimetric technique, directly measures heat, and does not depend on optical signals. It is therefore free from fluorescence artifacts such as quenching or light scattering, and is compatible with most buffers, excipients, and co-solutes, including detergents. DSC in combination with intrinsic DSF often delivers complimentary data output, if the sample has tryptophan in the structure (Fig. 3, DSC (red), intrinsic DSF (blue)). When one needs to rely on external fluorescence, the method can be susceptible to optical artifacts in certain samples or buffer conditions, and data interpretation can require additional expertise or complementary analysis. The extrinsic fluorescence data clearly show a significant shift towards low wavelength upon heating (so-called blue shift as opposed to the red shift postulated for a typical DSF experiment) (Fig. 3, extrinsic fluorescence (yellow)). This is a practical consideration when designing stability workflows, particularly for complex formulations or non-standard sample types.
![[Figure 3 WP160725stabilitybuyers - A Buyer's Guide to Stability Measurement Platforms for Biopharmaceuticals.jpg] Figure 3 v3 WP160725stabilitybuyers.jpg](https://dam.malvernpanalytical.com/81d9a4c1-f4fb-4fdb-bf69-b2ea008b736c/Figure%203%20v3%20WP160725stabilitybuyers_Original%20file.jpg)
Figure 3: The thermal unfolding of a mAb as observed as barycentric mean of intrinsic fluorescence (blue) is in good agreement with the DSC results (red). The profile of extrinsic fluorescence (yellow) displays a significant shift towards low wavelength upon heating.
An important practical consideration when selecting a protein stability measurement platform is the overall cost of ownership, including sample consumption, throughput, consumables, reagents, and day-to-day workflow requirements. Fluorescence-based DSF methods can offer clear practical advantages for low-volume, higher-throughput screening, particularly when many candidates or formulation conditions need to be compared. At the same time, the type and cost of plates, optical consumables, and assay reagents should be factored in, as these can influence the cost per data point and the consistency of the workflow over time. In this context, it would be desirable for DSF platforms to support standardized, broadly available plate formats, as this could help reduce consumable costs, simplify assay setup, and support more consistent measurements across studies.
DSC, as a label-free calorimetric technique, typically requires no additional reagents or optical consumables for routine operation, which can contribute to predictable running costs and a straightforward workflow. The robust design of DSC systems can also support long instrument lifetime and low maintenance requirements, adding to their long-term cost-effectiveness. Rather than viewing these considerations favoring one approach over the other, they are best evaluated alongside the scientific question, throughput needs, sample availability, and budget at each stage of a project.
Investing in a DSC or DSF instrument from a reputable, technology-leading company ensures high manufacturing standards and reliable, publication-quality results. Choose a manufacturer with a proven track record at the forefront of developing and optimizing these technologies. These companies produce instruments with good machine-to-machine variability and are more likely to provide ongoing innovations and robust support.
Purchasing an instrument initiate a long-term relationship with the vendor. Choosing a company that offers extensive service options – telephone, in-person, email and training opportunities, field service, and expert-level assistance – ensures that you receive the necessary support throughout the instrument's lifecycle.
DSC and DSF are complementary technologies that serve different and important roles in a biologics development workflow. DSF offers speed, throughput, and efficiency for early-stage screening, making it a valuable tool for rapid triage and candidate deselection. DSC provides the depth, reproducibility, and direct thermodynamic insight needed for confident decision-making at every subsequent stage: candidate selection, formulation development, comparability assessment, and regulatory submissions.
Investing in a high-quality DSC platform, like the Malvern Panalytical PEAQ-DSC, equips researchers and developers with an unparalleled tool for protein and other biomolecular stability analysis. Its comprehensive capabilities not only streamline the development process but also enhance the quality and efficacy of biotherapeutic and vaccine products, ultimately benefiting patients worldwide.
Looking ahead, the convergence of multiple stability measurement techniques into unified, high-throughput platforms is reshaping what is possible in the earliest stages of biologics development, extending the depth of characterization previously reserved for individual cuvette-based instruments to the scale and speed that modern candidate screening demands. As the biologics development landscape accelerates, so must the instruments that support it.